Charles River (CRL) Beats Q3 Views by 5c; Lowers FY09 EPS Guidance
CRL Hot Sheet
Revenue Growth %: +0.1%Financial Fact:
Other, net: -344K
Today's EPS Names:
RAH, NAVR, UVV, More
Charles River Laboratories International, Inc. (NYSE: CRL) reports Q3 adjusted EPS of $0.65, 5 cents better than the analyst estimate of $0.60. Revenue for the quarter was $297 million, which compares to the estimate of $306.95 million.
Lower FY09 EPS guidance to $2.28 - $2.32, versus $2.42 consensus.
Lower FY09 EPS guidance to $2.28 - $2.32, versus $2.42 consensus.
You May Also Be Interested In
- UPDATE: Ralph Lauren Corp (RL) Reports Solid Q4 Results; Guides FY13 Sales
- Analog Devices, Inc. (ADI) Tops Q2 EPS by 2c; Guides In-line
- Guess?, Inc. (GES) Tops Q1 EPS by 3c; Guides Q2, Reaffirms FY13
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
